logo

For the Inventor, By the Inventor

Needham, MA, United States of America

Verastem, Inc.


USPTO Granted Patents = 13

% Expired Patents = 46.2



Trademarks = 6

Forward Citations = 20

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Jonathan A Pachter (4 out of 5 patents)

silverMedal Meredith Williams (4 out of 10 patents)

bronzeMedal DiZhong Chen (2 out of 11 patents)

4.  Jennifer E Ring (2 out of 2 patents)

5.  David T Weaver (2 out of 2 patents)

6.  Yan Wang (2 out of 2 patents)

7.  Farzaneh Seyedi (2 out of 7 patents)

8.  Qunli Xu (2 out of 3 patents)

9.  Winnie Tam (2 out of 2 patents)

10.  Harish K Nagaraj (2 out of 2 patents)

11.  Michael Luzzio (1 out of 54 patents)

12.  Andrew Xian Chen (1 out of 37 patents)

13.  Hui-Yin Li (1 out of 34 patents)

14.  Yixiong Lei (1 out of 1 patent)

15.  Carl Henry Behrens (1 out of 13 patents)


13 patents:

1. 12509450 - Solid forms of a dual RAF/MEK inhibitor (2025-12-30),
2. 11873296 - Solid forms of a dual RAF/MEK inhibitor (2024-01-16),
3. 11564927 - Therapeutic compositions, combinations, and methods of use (2023-01-31),
4. 10532056 - Therapeutic compositions, combinations, and methods of use (2020-01-14),
5. 10406158 - Methods and compositions for treating abnormal cell growth (2019-09-10),
6. 9962385 - Methods and compositions for treating abnormal cell growth (2018-05-08),
7. 9505719 - Synthesis and use of kinase inhibitors (2016-11-29),
8. 9375402 - Oral formulations of kinase inhibitors (2016-06-28),
9. 9138437 - Pyrimidine substituted purine compounds as kinase (S) inhibitors (2015-09-22),
10. 8754080 - Pyrimidine substituted purine compounds as kinase (S) inhibitors (2014-06-17),
11. 8722884 - Pyrimidine derivatives for the treatment of abnormal cell growth (2014-05-13),
12. 8609838 - Pyrimidine substituted purine derivatives (2013-12-17),
13. 8247410 - Pyrimidine substituted purine derivatives (2012-08-21),
Company Overview
Verastem, Inc. is a biopharmaceutical company based in Needham, Massachusetts, focused on developing and commercializing innovative therapies for cancer treatment. The company specializes in targeted therapies that aim to address the underlying mechanisms of cancer, particularly in hematologic malignancies and solid tumors. Verastem's research emphasizes the importance of understanding cancer biology to create effective treatment options, contributing to advancements in oncology and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#14 in Needham, MA

#1,443 in Massachusetts

#23,854 in US

#45,081 in the World

Needham, MA (US)
Needham, MA, United States of America

Verastem, Inc.

Forward Citations = 20

21 inventors:

goldMedal Jonathan A Pachter (4 out of 5 patents)

silverMedal Meredith Williams (4 out of 10 patents)

bronzeMedal DiZhong Chen (2 out of 11 patents)

4.  Jennifer E Ring (2 out of 2 patents)

5.  David T Weaver (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Verastem, Inc.. Retrieved from https://idiyas.com/company/verastem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…